Higher, but not extremely high, HDL-C and/or apoA-I levels have been linked to better survival outcomes in cancer and MM patients, partly due to antineoplastic effects of apoA-I [10,26,59]. This evidence concerns the gene APOA1 and Miyoshi myopathy.